INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 48 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $8,000 | – | 321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hillview Capital Advisors, LLC | 19,610 | $45,000 | 0.27% |
| Magnus Financial Group LLC | 49,500 | $114,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 142,889 | $330,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 26,500 | $61,000 | 0.01% |
| FIRST QUADRANT LLC/CA | 23,700 | $55,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 2,572 | $6,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,400 | $10,000 | 0.00% |
| UBS Group AG | 13,791 | $32,000 | 0.00% |
| Legal & General Group Plc | 2,758 | $6,000 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 20,600 | $48,000 | 0.00% |